Tocilizumab, marketed under the brand name Actemra among others, is a medication used to treat rheumatoid arthritis, cytokine release syndrome, and certain other autoimmune diseases. It is a humanized monoclonal antibody that targets the interleukin-6 receptor (IL-6R). By blocking the action of IL-6, Tocilizumab reduces inflammation and improves symptoms in patients with these conditions.

The "Tocil" aspect of this phenomenon refers to a sense of preserved innocence. In a rapidly modernizing world where teenagers are forced to grow up quickly due to social media and academic pressure, retaining "Tocil" traits can be a defense mechanism. This behavior is characterized by simplicity, genuine emotional expression, and a lack of cynicism. For example, the way an ABG might obsess over a crush—using code names, exchanging shy glances, or maintaining a diary—mirrors the innocent affections of an elementary school student. This "Tocil" behavior serves a vital psychological purpose: it acts as a sanctuary where teenagers can retreat from the complex social politics of high school to a safer, simpler mindset.